Longer-Term Follow-Up from a Bariatric Surgery Trial for Diabetic Patients
At 3 years, glycemic control and quality of life were better with surgery than with medical management. In a previously published report from a randomized Cleveland Clinic trial, Roux-en-Y gastric bypass and sleeve gastrectomy were more likely than medical therapy (42% and 37% vs. 12%) to lower glycosylated hemoglobin (HbA1c)
Continua a leggere